Authors:
HO WZ
LAI JP
DOUGLAS SD
POMERANTZ RJ
STARR SE
Citation: Wz. Ho et al., INHIBITION OF HIV-1 REPLICATION IN CHRONICALLY INFECTED MONOCYTES ANDT-CELLS BY RETROVIRAL-MEDIATED GENE-TRANSFER OF ANTI-REV SINGLE-CHAINFRAGMENT, Journal of investigative medicine, 46(1), 1998, pp. 173-173
Authors:
ADLER SP
HEMPFLING SH
STARR SE
PLOTKIN SA
RIDDELL S
Citation: Sp. Adler et al., SAFETY AND IMMUNOGENICITY OF THE TOWNE STRAIN CYTOMEGALOVIRUS VACCINE, The Pediatric infectious disease journal, 17(3), 1998, pp. 200-206
Authors:
HO WZ
LAI JP
BOUHAMDAN M
DUAN LX
POMERANTZ RJ
STARR SE
Citation: Wz. Ho et al., INHIBITION OF HIV TYPE-1 REPLICATION IN CHRONICALLY INFECTED MONOCYTES AND LYMPHOCYTES BY RETROVIRUS-MEDIATED GENE-TRANSFER OF ANTI-REV SINGLE-CHAIN VARIABLE FRAGMENTS, AIDS research and human retroviruses, 14(17), 1998, pp. 1573-1580
Citation: Wz. Ho et al., L-2-OXOTHIAZOLIDINE-4-CARBOXYLIC ACID INHIBITS HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION IN MONONUCLEAR PHAGOCYTES AND LYMPHOCYTES, Clinical and diagnostic laboratory immunology, 4(3), 1997, pp. 352-357
Citation: S. Torigoe et al., CYTOKINES RELEASED BY HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS INHIBIT THE PRODUCTION OF EARLY AND LATE CYTOMEGALOVIRUS PROTEINS, Microbiology and immunology, 41(5), 1997, pp. 403-413
Citation: J. Chehimi et al., HIV-1 INFECTION OF HUMAN PERIPHERAL-BLOOD, CORD-BLOOD AND TONSILLAR DENDRITIC CELLS, Perspectives in drug discovery and design, 5, 1996, pp. 103-116
Authors:
NGAI AL
STAEHLE BO
KUTER BJ
CYANOVICH NM
CHO I
MATTHEWS H
KELLER P
ARVIN AM
WATSON B
WHITE CJ
ANDERSON R
ARBETER A
ARVIN AM
BLACK S
BLOCK SL
BLUMBERG D
BRUNELL PA
CHARTRAND SA
CLEMENTS DA
DENNEHY P
KEYSERLING H
NAUERT B
REISINGER KS
RENNELS MB
REUMAN PD
SHEHAB ZM
STARR SE
TUCKER R
Citation: Al. Ngai et al., SAFETY AND IMMUNOGENICITY OF ONE VS 2 INJECTIONS OF OKA MERCK VARICELLA VACCINE IN HEALTHY-CHILDREN/, The Pediatric infectious disease journal, 15(1), 1996, pp. 49-54
Authors:
ADLER SP
WANG JB
BURKE RL
DULIEGE AM
STARR SE
PLOTKIN SA
Citation: Sp. Adler et al., MUCOSAL ANTIBODIES TO CYTOMEGALOVIRUS (CMV) GLYCOPROTEIN-B (GB) OCCURFOLLOWING BOTH NATURAL INFECTION AND IMMUNIZATION WITH CMV VACCINES, Pediatric research, 39(4), 1996, pp. 973-973
Authors:
KIMBERLIN DW
LAKEMAN FD
ARVIN AM
PROBER CG
COREY L
POWELL DA
BURCHETT SK
JACOBS RF
STARR SE
WHITLEY RJ
SOONG SJ
STAGNO S
PASS R
ROBINSON J
VAUDRY W
JACOBS R
ARVIN A
PROBER C
BRADLEY J
SPECTOR S
KOVACS A
BRYSON Y
RATHORE M
REUMAN P
KEYSERLING H
DIAZ P
BALE J
LAUDERT S
STEELE R
VANDYKE R
LAUGHLIN C
BURCHETT S
MEISSNER C
DESIERRA M
KINNEY J
STORCH G
MODLIN J
WEINER L
LEISTIKOW E
MCKINNEY R
KUMAR M
POWELL D
STANBERRY L
GRUBER W
SANDER C
DEMMLER G
CHONMAITREE T
LEACH C
SHELTON M
ADLER S
COREY L
GROSS J
Citation: Dw. Kimberlin et al., APPLICATION OF THE POLYMERASE CHAIN-REACTION TO THE DIAGNOSIS AND MANAGEMENT OF NEONATAL HERPES-SIMPLEX VIRUS-DISEASE, The Journal of infectious diseases, 174(6), 1996, pp. 1162-1167
Authors:
WANG JB
ADLER SP
HEMPFLING S
BURKE RL
DULIEGE AM
STARR SE
PLOTKIN SA
Citation: Jb. Wang et al., MUCOSAL ANTIBODIES TO HUMAN CYTOMEGALOVIRUS GLYCOPROTEIN-B OCCUR FOLLOWING BOTH NATURAL INFECTION AND IMMUNIZATION WITH HUMAN CYTOMEGALOVIRUS VACCINES, The Journal of infectious diseases, 174(2), 1996, pp. 387-392
Authors:
WATSON BM
LAUFER DS
KUTER BJ
STAEHLE B
WHITE CJ
STARR SE
Citation: Bm. Watson et al., SAFETY AND IMMUNOGENICITY OF A COMBINED LIVE ATTENUATED MEASLES, MUMPS, RUBELLA, AND VARICELLA VACCINE (MMR(II)V) IN HEALTHY-CHILDREN (VOL 173, PG 731, 1996), The Journal of infectious diseases, 173(6), 1996, pp. 1529-1529
Authors:
WATSON B
BOARDMAN C
LAUFER D
PIERCY S
TUSTIN N
OLALEYE D
CNAAN A
STARR SE
Citation: B. Watson et al., HUMORAL AND CELL-MEDIATED IMMUNE-RESPONSES IN HEALTHY-CHILDREN AFTER ONE OR 2 DOSES OF VARICELLA VACCINE, Clinical infectious diseases, 20(2), 1995, pp. 316-319
Authors:
WATSON B
ROTHSTEIN E
BERNSTEIN H
ARBETER A
ARVIN A
CHARTRAND S
CLEMENTS D
KUMAR ML
REISINGER K
BLATTER M
STARR SE
STAEHLE B
NGAI A
WHITE CJ
Citation: B. Watson et al., SAFETY AND CELLULAR AND HUMORAL IMMUNE-RESPONSES OF A BOOSTER DOSE OFVARICELLA VACCINE 6 YEARS AFTER PRIMARY IMMUNIZATION, The Journal of infectious diseases, 172(1), 1995, pp. 217-219
Authors:
ADLER SP
STARR SE
PLOTKIN SA
HEMPFLING SH
BUIS J
MANNING ML
BEST AM
Citation: Sp. Adler et al., IMMUNITY INDUCED BY PRIMARY HUMAN CYTOMEGALOVIRUS-INFECTION PROTECTS AGAINST SECONDARY INFECTION AMONG WOMEN OF CHILDBEARING AGE, The Journal of infectious diseases, 171(1), 1995, pp. 26-32
Authors:
ADLER SP
HEMPFLING SH
STARR SE
PLOTKIN SA
Citation: Sp. Adler et al., AMONG WOMEN OF CHILDBEARING AGE ANTIBODIES INDUCED BY A PRIMARY CYTOMEGALOVIRUS (CMV) PROTECT AGAINST SECONDARY INFECTION, Pediatric research, 35(4), 1994, pp. 10000173-10000173
Citation: Bm. Watson et al., SPECIFIC CELLULAR IMMUNE-RESPONSES FOLLOWING A BOOSTER DOSE OF VARICELLA VACCINE AT 6 YEARS POST IMMUNIZATION, Pediatric research, 35(4), 1994, pp. 10000200-10000200
Authors:
WATSON B
LAUFER D
PIERCY S
TUSTIN N
STARR SE
Citation: B. Watson et al., SAFETY AND IMMUNOGENICITY OF LIVE ATTENUATED MEASLES, MUMPS, RUBELLA AND VARICELLA VACCINE (MMRII-V) IN HEALTHY-CHILDREN, Pediatric research, 35(4), 1994, pp. 10000200-10000200
Authors:
CHEHIMI J
STARR SE
FRANK I
DANDREA A
MA XJ
MACGREGOR RR
SENNELIER J
TRINCHIERI G
Citation: J. Chehimi et al., IMPAIRED INTERLEUKIN-12 PRODUCTION IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS, The Journal of experimental medicine, 179(4), 1994, pp. 1361-1366